Product brand · Fictional sample
NEXTGENART
NEXTGENART 100 mg film-coated tablets
Fictional oral ALG1 inhibitor (algotinib) for ALG1 fusion-positive non-small cell lung cancer, the same product as the NEXTGENART sample documents in the SmPC Analyzer. Product identity: a wordmark with a signature arc, Algotinib Amber as the only accent, and strength colour coding prepared for a second strength.
- Brand type
- Identity of one medicinal product. Inherits the company rules and may override single rules.
- Company brand
- Packart Demo Pharma
- INN
- algotinib
- Therapeutic area
- Oncology · NSCLC
- Markets
- EU, US
- Brand owner
- Hidden in the limited viewer
8Assets
32Rules · 18 inherited
27Must
5Should / may
Effective rule set
Rules per packaging component
Company rules of Packart Demo Pharma plus the rules of NEXTGENART, with overrides applied.
Assets